TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Reinventing NCI: Prevention Program Lacks Leadership, Reorganization Needed, Advisory Group Says June 20, 1997
TCL Archive New ACR Mammography Guidelines Suggest Annual Screening For Women Age 40-50 November 12, 1982
